University of Lethbridge researching possible Parkinson’s disease treatments

As published in CTV News Calgary

The University of Lethbridge has been chosen to research GB Sciences’ new patent-protected formulations of a potential Parkinson’s disease (PD) treatment.

Led by Dr. Robert Sutherland, the study will focus on the cannabis-based formulations as a way to potentially slow down or possibly reverse the symptoms of PD.

One cause of PD is the death of nerve cells in the basal ganglia. This area of the brain controls bodily movement, and the cells that die are dopamine-producing cells. The lack of dopamine produced by the basal ganglia results in some of the common symptoms, like shakiness, difficulty with coordination and balance issues.

Read the full article here.